Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of 627 for Ulcerative Colitis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• 627

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: NOT_YET_RECRUITING